New procedure aims to cut repeat brain bleed surgeries
NCT ID NCT07626671
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a minimally invasive procedure called middle meningeal artery embolization (MMAE) for chronic subdural hematoma, a common brain bleed in older adults. The procedure blocks the blood supply to the hematoma membrane to prevent rebleeding. Researchers will follow 100 patients for 4 months to see if it reduces hematoma size, improves function, and lowers the need for repeat surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Middle meningeal artery embolization (minimally invasive procedure to block blood flow to the hematoma membrane)
What this could lead to
If successful, this could establish a standard follow-up and identify which patients benefit most from MMA embolization, reducing the need for repeat surgeries.
What could go wrong
This is a single-center registry with only 100 patients, so results may not apply broadly. The procedure itself carries small risks like bleeding or stroke, and it may not work for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SUBDURAL HEMATOMAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••